Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News | Peripheral Artery Disease (PAD)

June 16, 2020 — The 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent ...

Home June 16, 2020
Home
News | Stents

May 28, 2020 — The rising incidence of cardiovascular disease has prompted people to seek timely treatment to improve ...

Home May 28, 2020
Home
News | Robotic Systems

May 28, 2020 — Hoag Memorial Hospital Presbyterian recently became the first hospital on the West Coast to perform an ...

Home May 28, 2020
Home
News | Stents

May 17, 2020 – A new study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP) ...

Home May 17, 2020
Home
News | Stents

February 24, 2020 — Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the ...

Home February 24, 2020
Home
News | Cardiovascular Business

February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced the ...

Home February 19, 2020
Home
The Boston Scientific Eluvia self-expanding, drug-eluting, peripheral stent.
Feature | Stents | Saloni Walimbe

Cardiovascular diseases (CVDs) are among the leading causes of death across the globe. For patients suffering from high ...

Home February 11, 2020
Home
News | Cath Lab | Dave Fornell, Editor

January 2, 2020 — In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdre ...

Home January 02, 2020
Home
The American Heart Association, AHA, 2019 meeting late breaking trials and key studies on cardiovascular science.
Feature | AHA | Dave Fornell, Editor

November 19, 2019 — Here is a list of the key late-breaking clinical study presentations and links to the results at the ...

Home November 19, 2019
Home
News | Stents Carotid

November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...

Home November 11, 2019
Home
News

November 8, 2019 — The Absorb bioresorbable stent (BVS) demonstrated good patency and clinical outcomes in patients with ...

Home November 08, 2019
Home
News | Stents Bioresorbable

November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...

Home November 07, 2019
Home
The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) were evaluated to determine if there is an increased mortality risk due to paclitaxel, but was no difference was seen in the five-year mortality rates compared to control patients. #VIVA19 #VIVA #VIVA2019
Feature | Stents Peripheral | Dave Fornell, Editor

November 6, 2019 – The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) ...

Home November 06, 2019
Home
News | Peripheral Artery Disease (PAD)

November 6, 2019 – Boston Scientific announced positive data for two of its devices within the peripheral drug-eluting ...

Home November 06, 2019
Home
Viva conference late breaking clinical trials, #VIVA19 #VIVA #VIVA2019
Feature | VIVA

November 14, 2019 — The results of the 21 late-breaking clinical trials presented for the first time at Vascular ...

Home November 14, 2019
Home
Subscribe Now